Announcement

AMA: Changes in Medicare Physician Spending During the COVID-19 Pandemic

News

Emergent HBO2 Access Issue

Emergent HBO2 Access Issue White Paper - Access to emergent hyperbaric oxygen (HBO2) therapy: an urgent problem in health care delivery in the United States Open Letter - Emergency hyperbaric oxygen therapy – a service in need of resuscitation…

News

FDA recommends UHMS-accredited hyperbaric facilities for treatment of specific illnesses

In a July 26 release entitled “Hyperbaric Oxygen Therapy: Get the Facts” the U.S. Food and Drug Administration (FDA) has cleared the use of hyperbaric oxygen therapy (HBOT/HBO2) for the treatment of several conditions. The release further states: “If your health care provider recommends HBOT, the FDA advises you get the treatment at a hospital or facility that has been inspected and is accredited by the Undersea and Hyperbaric Medical Society.”

Announcement

Volume 50: The Uhm Journal Celebrates A Milestone With The Publication Of This Issue